You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 255 No. 2, January 10, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (73)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evidence That Men With Familial Hypercholesterolemia Can Avoid Early Coronary Death

An Analysis of 77 Gene Carriers in Four Utah Pedigrees

Roger R. Williams, MD; Sandra J. Hasstedt, PhD; Dana E. Wilson, MD; K. Owen Ash, PhD; Frank F. Yanowitz, MD; Gayle E. Reiber, RN, MPH; Hiroshi Kuida, MD

JAMA. 1986;255(2):219-224.


Abstract

To study the genetic influence on serum cholesterol levels and early coronary heart disease, 1,134 individuals were screened from 18 Utah pedigrees. In most pedigrees, serum cholesterol appeared to be a purely polygenic trait, with 54% heritability. In four pedigrees with dominant familial hypercholesterolemia, male heterozygotes had a mean serum cholesterol level of 352 mb/dL, myocardial infarction at an average age of 42 years, and coronary death at an average age of 45 years. An informative pedigree structure allowed the identification of four ancestral males born before 1880 who carried this lethal gene and survived to ages 62, 68, 72, and 81 years. This suggests that some healthy life-style factors protected these men against the expression of a gene that has led to coronary disease by age 45 years in all of their heterozygous great-grandsons. One heterozygote showed a drop in serum cholesterol level from 426 to 248 mg/dL, with strict adherence to a low-fat diet without drugs. These observations should help encourage physicians to try harder to identify and help such individuals.

(JAMA 1986;255:219-224)



Author Affiliations

From the Departments of Internal Medicine, Cardiology Division (Drs Williams, Yanowitz, and Kuida) and Metabolism Division (Dr Wilson), Human Genetics (Dr Hasstedt), and Pathology (Dr Ash), University of Utah School of Medicine; and the Bureau of Chronic Disease Control, Utah State Department of Health (Ms Reiber), Salt Lake City.


Footnotes

Reprint requests to Division of Cardiology, University of Utah Medical Center, 50 N Medical Dr, Salt Lake City, UT 84132 (Dr Williams).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review
Austin et al.
Am J Epidemiol 2004;160:407-420.
ABSTRACT | FULL TEXT  

Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review
Austin et al.
Am J Epidemiol 2004;160:421-429.
ABSTRACT | FULL TEXT  

Genetic Risk in Context: Calculating the Penetrance of BRCA1 and BRCA2 Mutations
Burke and Austin
JNCI J Natl Cancer Inst 2002;94:1185-1187.
FULL TEXT  

Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study Commentary: Role of other genes and environment should not be overlooked in monogenic disease
Sijbrands et al.
BMJ 2001;322:1019-1023.
ABSTRACT | FULL TEXT  

Cardiorespiratory Fitness and Coronary Heart Disease Risk Factors : The LDS Hospital Fitness Institute Cohort
LaMonte et al.
Circulation 2000;102:1623-1628.
ABSTRACT | FULL TEXT  

Evidence for a third genetic locus causing familial hypercholesterolemia: a non-LDLR, non-APOB kindred
Haddad et al.
J. Lipid Res. 1999;40:1113-1122.
ABSTRACT | FULL TEXT  

Relationships of Abdominal Obesity and Hyperinsulinemia to Angiographically Assessed Coronary Artery Disease in Men With Known Mutations in the LDL Receptor Gene
Gaudet et al.
Circulation 1998;97:871-877.
ABSTRACT | FULL TEXT  

Mutations in the Gene for Lipoprotein Lipase : A Cause for Low HDL Cholesterol Levels in Individuals Heterozygous for Familial Hypercholesterolemia
Pimstone et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1704-1712.
ABSTRACT | FULL TEXT  

Familial Hypercholesterolemia and Early Coronary Death
Ravenholt
JAMA 1986;256:348-348.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.